Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database

Patrick Petrossians, Adrian F Daly, Emil Natchev, Luigi Maione, Karin Blijdorp, Mona Sahnoun-Fathallah, Renata Auriemma, Alpha M Diallo, Anna-Lena Hulting, Diego Ferone, Vaclav Hana, Silvia Filipponi, Caroline Sievers, Claudia Nogueira, Carmen Fajardo-Montañana, Davide Carvalho, Vaclav Hana, Günter K Stalla, Marie-Lise Jaffrain-Réa, Brigitte DelemerAnnamaria Colao, Thierry Brue, Sebastian J C M M Neggers, Sabina Zacharieva, Philippe Chanson, Albert Beckers

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Acromegaly is a rare disorder caused by chronic growth hormone (GH) hypersecretion. While diagnostic and therapeutic methods have advanced, little information exists on trends in acromegaly characteristics over time. The Liège Acromegaly Survey (LAS) Database, a relational database, is designed to assess the profile of acromegaly patients at diagnosis and during long-term follow-up at multiple treatment centers. The following results were obtained at diagnosis. The study population consisted of 3173 acromegaly patients from ten countries; 54.5% were female. Males were significantly younger at diagnosis than females (43.5 vs 46.4 years; P < 0.001). The median delay from first symptoms to diagnosis was 2 years longer in females (P = 0.015). Ages at diagnosis and first symptoms increased significantly over time (P < 0.001). Tumors were larger in males than females (P < 0.001); tumor size and invasion were inversely related to patient age (P < 0.001). Random GH at diagnosis correlated with nadir GH levels during OGTT (P < 0.001). GH was inversely related to age in both sexes (P < 0.001). Diabetes mellitus was present in 27.5%, hypertension in 28.8%, sleep apnea syndrome in 25.5% and cardiac hypertrophy in 15.5%. Serious cardiovascular outcomes like stroke, heart failure and myocardial infarction were present in <5% at diagnosis. Erythrocyte levels were increased and correlated with IGF-1 values. Thyroid nodules were frequent (34.0%); 820 patients had colonoscopy at diagnosis and 13% had polyps. Osteoporosis was present at diagnosis in 12.3% and 0.6-4.4% had experienced a fracture. In conclusion, this study of >3100 patients is the largest international acromegaly database and shows clinically relevant trends in the characteristics of acromegaly at diagnosis.

Original languageEnglish
Pages (from-to)505-518
Number of pages14
JournalEndocrine-Related Cancer
Volume24
Issue number10
DOIs
Publication statusPublished - Oct 2017

Fingerprint

Acromegaly
Databases
Surveys and Questionnaires
Growth Hormone
Therapeutics
Population

Keywords

  • Journal Article

Cite this

Petrossians, P., Daly, A. F., Natchev, E., Maione, L., Blijdorp, K., Sahnoun-Fathallah, M., ... Beckers, A. (2017). Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database. Endocrine-Related Cancer, 24(10), 505-518. https://doi.org/10.1530/ERC-17-0253

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database. / Petrossians, Patrick; Daly, Adrian F; Natchev, Emil; Maione, Luigi; Blijdorp, Karin; Sahnoun-Fathallah, Mona; Auriemma, Renata; Diallo, Alpha M; Hulting, Anna-Lena; Ferone, Diego; Hana, Vaclav; Filipponi, Silvia; Sievers, Caroline; Nogueira, Claudia; Fajardo-Montañana, Carmen; Carvalho, Davide; Hana, Vaclav; Stalla, Günter K; Jaffrain-Réa, Marie-Lise; Delemer, Brigitte; Colao, Annamaria; Brue, Thierry; Neggers, Sebastian J C M M; Zacharieva, Sabina; Chanson, Philippe; Beckers, Albert.

In: Endocrine-Related Cancer, Vol. 24, No. 10, 10.2017, p. 505-518.

Research output: Contribution to journalArticle

Petrossians, P, Daly, AF, Natchev, E, Maione, L, Blijdorp, K, Sahnoun-Fathallah, M, Auriemma, R, Diallo, AM, Hulting, A-L, Ferone, D, Hana, V, Filipponi, S, Sievers, C, Nogueira, C, Fajardo-Montañana, C, Carvalho, D, Hana, V, Stalla, GK, Jaffrain-Réa, M-L, Delemer, B, Colao, A, Brue, T, Neggers, SJCMM, Zacharieva, S, Chanson, P & Beckers, A 2017, 'Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database', Endocrine-Related Cancer, vol. 24, no. 10, pp. 505-518. https://doi.org/10.1530/ERC-17-0253
Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M et al. Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database. Endocrine-Related Cancer. 2017 Oct;24(10):505-518. https://doi.org/10.1530/ERC-17-0253
Petrossians, Patrick ; Daly, Adrian F ; Natchev, Emil ; Maione, Luigi ; Blijdorp, Karin ; Sahnoun-Fathallah, Mona ; Auriemma, Renata ; Diallo, Alpha M ; Hulting, Anna-Lena ; Ferone, Diego ; Hana, Vaclav ; Filipponi, Silvia ; Sievers, Caroline ; Nogueira, Claudia ; Fajardo-Montañana, Carmen ; Carvalho, Davide ; Hana, Vaclav ; Stalla, Günter K ; Jaffrain-Réa, Marie-Lise ; Delemer, Brigitte ; Colao, Annamaria ; Brue, Thierry ; Neggers, Sebastian J C M M ; Zacharieva, Sabina ; Chanson, Philippe ; Beckers, Albert. / Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database. In: Endocrine-Related Cancer. 2017 ; Vol. 24, No. 10. pp. 505-518.
@article{853009d6c2ef47f7a4a257444a379e5c,
title = "Acromegaly at diagnosis in 3173 patients from the Li{\`e}ge Acromegaly Survey (LAS) Database",
abstract = "Acromegaly is a rare disorder caused by chronic growth hormone (GH) hypersecretion. While diagnostic and therapeutic methods have advanced, little information exists on trends in acromegaly characteristics over time. The Li{\`e}ge Acromegaly Survey (LAS) Database, a relational database, is designed to assess the profile of acromegaly patients at diagnosis and during long-term follow-up at multiple treatment centers. The following results were obtained at diagnosis. The study population consisted of 3173 acromegaly patients from ten countries; 54.5{\%} were female. Males were significantly younger at diagnosis than females (43.5 vs 46.4 years; P < 0.001). The median delay from first symptoms to diagnosis was 2 years longer in females (P = 0.015). Ages at diagnosis and first symptoms increased significantly over time (P < 0.001). Tumors were larger in males than females (P < 0.001); tumor size and invasion were inversely related to patient age (P < 0.001). Random GH at diagnosis correlated with nadir GH levels during OGTT (P < 0.001). GH was inversely related to age in both sexes (P < 0.001). Diabetes mellitus was present in 27.5{\%}, hypertension in 28.8{\%}, sleep apnea syndrome in 25.5{\%} and cardiac hypertrophy in 15.5{\%}. Serious cardiovascular outcomes like stroke, heart failure and myocardial infarction were present in <5{\%} at diagnosis. Erythrocyte levels were increased and correlated with IGF-1 values. Thyroid nodules were frequent (34.0{\%}); 820 patients had colonoscopy at diagnosis and 13{\%} had polyps. Osteoporosis was present at diagnosis in 12.3{\%} and 0.6-4.4{\%} had experienced a fracture. In conclusion, this study of >3100 patients is the largest international acromegaly database and shows clinically relevant trends in the characteristics of acromegaly at diagnosis.",
keywords = "Journal Article",
author = "Patrick Petrossians and Daly, {Adrian F} and Emil Natchev and Luigi Maione and Karin Blijdorp and Mona Sahnoun-Fathallah and Renata Auriemma and Diallo, {Alpha M} and Anna-Lena Hulting and Diego Ferone and Vaclav Hana and Silvia Filipponi and Caroline Sievers and Claudia Nogueira and Carmen Fajardo-Monta{\~n}ana and Davide Carvalho and Vaclav Hana and Stalla, {G{\"u}nter K} and Marie-Lise Jaffrain-R{\'e}a and Brigitte Delemer and Annamaria Colao and Thierry Brue and Neggers, {Sebastian J C M M} and Sabina Zacharieva and Philippe Chanson and Albert Beckers",
note = "{\circledC} 2017 The authors.",
year = "2017",
month = "10",
doi = "10.1530/ERC-17-0253",
language = "English",
volume = "24",
pages = "505--518",
journal = "Endocrine-Related Cancer",
issn = "1351-0088",
publisher = "BioScientifica Ltd.",
number = "10",

}

TY - JOUR

T1 - Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database

AU - Petrossians, Patrick

AU - Daly, Adrian F

AU - Natchev, Emil

AU - Maione, Luigi

AU - Blijdorp, Karin

AU - Sahnoun-Fathallah, Mona

AU - Auriemma, Renata

AU - Diallo, Alpha M

AU - Hulting, Anna-Lena

AU - Ferone, Diego

AU - Hana, Vaclav

AU - Filipponi, Silvia

AU - Sievers, Caroline

AU - Nogueira, Claudia

AU - Fajardo-Montañana, Carmen

AU - Carvalho, Davide

AU - Hana, Vaclav

AU - Stalla, Günter K

AU - Jaffrain-Réa, Marie-Lise

AU - Delemer, Brigitte

AU - Colao, Annamaria

AU - Brue, Thierry

AU - Neggers, Sebastian J C M M

AU - Zacharieva, Sabina

AU - Chanson, Philippe

AU - Beckers, Albert

N1 - © 2017 The authors.

PY - 2017/10

Y1 - 2017/10

N2 - Acromegaly is a rare disorder caused by chronic growth hormone (GH) hypersecretion. While diagnostic and therapeutic methods have advanced, little information exists on trends in acromegaly characteristics over time. The Liège Acromegaly Survey (LAS) Database, a relational database, is designed to assess the profile of acromegaly patients at diagnosis and during long-term follow-up at multiple treatment centers. The following results were obtained at diagnosis. The study population consisted of 3173 acromegaly patients from ten countries; 54.5% were female. Males were significantly younger at diagnosis than females (43.5 vs 46.4 years; P < 0.001). The median delay from first symptoms to diagnosis was 2 years longer in females (P = 0.015). Ages at diagnosis and first symptoms increased significantly over time (P < 0.001). Tumors were larger in males than females (P < 0.001); tumor size and invasion were inversely related to patient age (P < 0.001). Random GH at diagnosis correlated with nadir GH levels during OGTT (P < 0.001). GH was inversely related to age in both sexes (P < 0.001). Diabetes mellitus was present in 27.5%, hypertension in 28.8%, sleep apnea syndrome in 25.5% and cardiac hypertrophy in 15.5%. Serious cardiovascular outcomes like stroke, heart failure and myocardial infarction were present in <5% at diagnosis. Erythrocyte levels were increased and correlated with IGF-1 values. Thyroid nodules were frequent (34.0%); 820 patients had colonoscopy at diagnosis and 13% had polyps. Osteoporosis was present at diagnosis in 12.3% and 0.6-4.4% had experienced a fracture. In conclusion, this study of >3100 patients is the largest international acromegaly database and shows clinically relevant trends in the characteristics of acromegaly at diagnosis.

AB - Acromegaly is a rare disorder caused by chronic growth hormone (GH) hypersecretion. While diagnostic and therapeutic methods have advanced, little information exists on trends in acromegaly characteristics over time. The Liège Acromegaly Survey (LAS) Database, a relational database, is designed to assess the profile of acromegaly patients at diagnosis and during long-term follow-up at multiple treatment centers. The following results were obtained at diagnosis. The study population consisted of 3173 acromegaly patients from ten countries; 54.5% were female. Males were significantly younger at diagnosis than females (43.5 vs 46.4 years; P < 0.001). The median delay from first symptoms to diagnosis was 2 years longer in females (P = 0.015). Ages at diagnosis and first symptoms increased significantly over time (P < 0.001). Tumors were larger in males than females (P < 0.001); tumor size and invasion were inversely related to patient age (P < 0.001). Random GH at diagnosis correlated with nadir GH levels during OGTT (P < 0.001). GH was inversely related to age in both sexes (P < 0.001). Diabetes mellitus was present in 27.5%, hypertension in 28.8%, sleep apnea syndrome in 25.5% and cardiac hypertrophy in 15.5%. Serious cardiovascular outcomes like stroke, heart failure and myocardial infarction were present in <5% at diagnosis. Erythrocyte levels were increased and correlated with IGF-1 values. Thyroid nodules were frequent (34.0%); 820 patients had colonoscopy at diagnosis and 13% had polyps. Osteoporosis was present at diagnosis in 12.3% and 0.6-4.4% had experienced a fracture. In conclusion, this study of >3100 patients is the largest international acromegaly database and shows clinically relevant trends in the characteristics of acromegaly at diagnosis.

KW - Journal Article

U2 - 10.1530/ERC-17-0253

DO - 10.1530/ERC-17-0253

M3 - Article

C2 - 28733467

VL - 24

SP - 505

EP - 518

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

SN - 1351-0088

IS - 10

ER -